Advertisement
Hoth Therapeutics Partners Altasciences For Study On HT-KIT Cancer Treatment
(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday that it has completed bioanalytical method development under its prior agreement with Altasciences.
The company now plans to further engage Altasciences to perform a key study of mouse blood and plasma analysis from samples collected in Hoth's sponsored scientific research conducted at NC State University.
The blood and plasma samples collected are part of a dose response study in a humanized mouse model.
The upcoming study will use the newly validated bioanalytical method developed at Altasciences to test the amount of HT-KIT from the dose response study and help determine how long HT-KIT remains in the blood stream post dosing.
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews
|
673 days ago
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.
RTTNews
|
929 days ago
Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Tuesday that it has signed an agreement with Altasciences, a fully integrated early phase CRO/CDMO, to develop and manufacture the HT-TBI drug product formulation.
RTTNews
|
1029 days ago
Swiss Market Fails To Hold Early Gains, Ends Weak
Despite spending much of the day's trading session in positive territory, the Switzerland market ended on a weak note on Tuesday as fears of a trade war rendered the mood a bit bearish.
RTTNews
|
2h 11min ago
European Stocks Close Lower On Trade Concerns, U.S. Inflation Data
European stocks closed lower on Tuesday, extending recent losses, despite some optimism about the European Union striking a trade deal with the U.S. in the coming weeks. Data showing an acceleration in U.S. inflation in the month of June hurt sentiment.
RTTNews
|
2h 35min ago
TSX Retreats After Hitting Fresh Record High; Materials Stocks Among Major Losers
The Canadian market is down in negative territory on Tuesday, weighed down by concerns about tariffs, and uncertainty about any monetary easing by the Bank of Canada following sticky inflation data.
RTTNews
|
3h 33min ago
New York Manufacturing Index Unexpectedly Indicates Growth In July
New York manufacturing activity has seen a notable turnaround in the month of July, according to a report released by the Federal Reserve Bank of New York on Tuesday. The New York Fed said its general business conditions index surged to a positive 5.5 in July from a negative 16.0 in June, with a positive reading indicating growth. Economists had expected the index to rise to a negative 10.0.
RTTNews
|
6h 37min ago
U.S. Consumer Prices Rise 0.3% In June, In Line With Estimates
The Labor Department released a report on Tuesday showing consumer prices in the U.S. increased in line with economist estimates in the month of June. The report said the consumer price index rose by 0.3 percent in June after inching up by 0.1 percent in May.
RTTNews
|
6h 40min ago
